Zhao R - Search Results

1

Quaroni L, Zhao R, Casson AG. Quaroni L, et al. Among authors: zhao r. Expert Rev Gastroenterol Hepatol. 2009 Dec;3(6):577-80. doi: 10.1586/egh.09.43. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19929578 No abstract available.

2

Fourier transform infrared (FTIR) spectromicroscopic characterization of stem-like cell populations in human esophageal normal and adenocarcinoma cell lines.

Zhao R, Quaroni L, Casson AG. Zhao R, et al. Analyst. 2010 Jan;135(1):53-61. doi: 10.1039/b914311d. Epub 2009 Nov 10. Analyst. 2010. PMID: 20024181

3

Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma.

Nguyen GH, Schetter AJ, Chou DB, Bowman ED, Zhao R, Hawkes JE, Mathé EA, Kumamoto K, Zhao Y, Budhu A, Hagiwara N, Wang XW, Miyashita M, Casson AG, Harris CC. Nguyen GH, et al. Among authors: zhao y, zhao r. Clin Cancer Res. 2010 Dec 1;16(23):5824-34. doi: 10.1158/1078-0432.CCR-10-1110. Epub 2010 Oct 14. Clin Cancer Res. 2010. PMID: 20947516 Free PMC article.

4

Obesity is not associated with adverse outcome following surgical resection of oesophageal adenocarcinoma.

Madani K, Zhao R, Lim HJ, Casson SM, Casson AG. Madani K, et al. Among authors: zhao r. Eur J Cardiothorac Surg. 2010 Nov;38(5):604-8. doi: 10.1016/j.ejcts.2010.03.054. Epub 2010 May 4. Eur J Cardiothorac Surg. 2010. PMID: 20444616

5

A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma.

MacDonald K, Porter GA, Guernsey DL, Zhao R, Casson AG. MacDonald K, et al. Among authors: zhao r. Cancer Epidemiol. 2009 Jul;33(1):37-40. doi: 10.1016/j.canep.2009.04.014. Epub 2009 May 28. Cancer Epidemiol. 2009. PMID: 19679045

6

Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.

Zhao R, DeCoteau JF, Geyer CR, Gao M, Cui H, Casson AG. Zhao R, et al. Carcinogenesis. 2009 Dec;30(12):2117-22. doi: 10.1093/carcin/bgp254. Carcinogenesis. 2009. PMID: 19843644

7

Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study.

Madani K, Zhao R, Lim HJ, Casson AG. Madani K, et al. Among authors: zhao r. Eur J Cardiothorac Surg. 2010 Jun;37(6):1427-32. doi: 10.1016/j.ejcts.2009.12.018. Epub 2010 Mar 12. Eur J Cardiothorac Surg. 2010. PMID: 20227286

8

Does previous fundoplication alter the surgical approach to esophageal adenocarcinoma?

Casson AG, Madani K, Mann S, Zhao R, Reeder B, Lim HJ. Casson AG, et al. Among authors: zhao r. Eur J Cardiothorac Surg. 2008 Nov;34(5):1097-101; discussion 1101-2. doi: 10.1016/j.ejcts.2008.07.059. Epub 2008 Sep 6. Eur J Cardiothorac Surg. 2008. PMID: 18774726

9

Epigenetic aberrations and targeted epigenetic therapy of esophageal cancer.

Zhao R, Casson AG. Zhao R, et al. Curr Cancer Drug Targets. 2008 Sep;8(6):509-21. doi: 10.2174/156800908785699306. Curr Cancer Drug Targets. 2008. PMID: 18781897 Review.

10

Insulin-like growth factor type I receptor gene expression and obesity in esophageal adenocarcinoma.

Zhao R, Macdonald K, Casson AG. Zhao R, et al. Mol Carcinog. 2009 Nov;48(11):982-8. doi: 10.1002/mc.20562. Mol Carcinog. 2009. PMID: 19582762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,567 results

Search Page